AGM/EGMJun 2, 2026, 04:07 PM
ProQR Shareholders Approve Capital Increase, Share Issuance, Auditor
AI Summary
ProQR Therapeutics N.V. shareholders approved several key proposals at the Annual Meeting, including the appointment of KPMG Accountants N.V. as the external auditor for the financial year 2027. Shareholders also approved amendments to the Articles of Association to increase authorized capital, and authorized the Board to issue and acquire ordinary shares. Additionally, the Board determined the new composition of its Audit, Compensation, Nominating and Corporate Governance, and Research and Development Committees, effective June 2, 2026.
Key Highlights
- Shareholders approved KPMG Accountants N.V. as external auditor for 2027 with 99.8% of votes.
- Shareholders approved amendment of Articles of Association to increase authorized capital with 65.4% of votes.
- Shareholders authorized the Board to issue ordinary shares with 64.3% of votes.
- Shareholders authorized the Board to acquire ordinary shares with 66.7% of votes.
- Bart Filius appointed Chair of the Audit Committee.
- Theresa Heggie appointed Chair of the Compensation, Nominating and Corporate Governance Committee.
- James Shannon appointed Chair of the Research and Development Committee.
Price Impact
More from PRQR